Why make patients exercise facial muscles for 4 hours after botulinum toxin treatment? [8]

Archives of Dermatology

Volumn 139, Issue 7, 2003, Pages 948-

  Hsu, Te Shao ^a   Dover, Jeffrey S ^b   Kaminer, Michael S ^b   Arndt, Kenneth A ^b   Tan, Mei Heng ^b  

^a SkinCare Physicians of Chestnut Hill   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN; CHOLINERGIC RECEPTOR;

DRUG BINDING; DRUG UPTAKE; FACE MUSCLE; FACIAL EXPRESSION; HUMAN; LETTER; MUSCLE EXCITATION; MUSCLE EXERCISE; NERVE ENDING; PATIENT SATISFACTION; PRESYNAPTIC NERVE; PRIORITY JOURNAL;

BOTULINUM TOXIN TYPE A; COSMETIC TECHNIQUES; EXERCISE; FACIAL MUSCLES; HUMANS; INJECTIONS, INTRAMUSCULAR; NEUROMUSCULAR AGENTS;

EID: 0345736002     PISSN: 0003987X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archderm.139.7.948-a     Document Type: Letter

References (3)

1. Huang W, Foster JA, Rogachefsky AS. Pharmacology of botulinum toxin. J Am Acad Dermatol. 2000;43(2 pt 1):249-259.
2. Benedetto AV. The cosmetic uses of botulinum toxin type A. Int J Dermatol. 1999;38:641-655.
3. Alam M, Dover JS, Arndt KA. Pain associated with injection of botulinum A exotoxin reconstituted using isotonic sodium chloride with and without preservative: a double-blind, randomized controlled trial. Arch Dermatol. 2002;138:510-514.